ym 872 has been researched along with ag-1296 in 1 studies
| Studies (ym 872) | Trials (ym 872) | Recent Studies (post-2010) (ym 872) | Studies (ag-1296) | Trials (ag-1296) | Recent Studies (post-2010) (ag-1296) |
|---|---|---|---|---|---|
| 41 | 0 | 5 | 121 | 2 | 36 |
| Protein | Taxonomy | ym 872 (IC50) | ag-1296 (IC50) |
|---|---|---|---|
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 0.8 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Ishiuchi, S; Ohtani, T; Watanabe, T | 1 |
1 other study(ies) available for ym 872 and ag-1296
| Article | Year |
|---|---|
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Glioblastoma; Humans; Imidazoles; In Vitro Techniques; Mice; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Quinoxalines; Receptors, AMPA; Receptors, Platelet-Derived Growth Factor; Transplantation, Heterologous; Treatment Outcome; Tyrphostins | 2013 |